Three-layered polyplex as a microRNA targeted delivery system for breast cancer gene therapy

Yan Li1, Yu Dai2, Xiaojin Zhang2

  • 1State Key Laboratory of Military Stomatology, Department of Prosthodontics, School of Stomatology, the Fourth Military Medical University, Xi'an 710032, People's Republic of China.

Nanotechnology
|June 20, 2017
PubMed

Insights

This study developed a targeted delivery system for microRNAs (miRNAs) to inhibit breast cancer growth. The novel three-layered polyplex effectively delivered miR-210 into cancer cells, reducing tumor progression.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • MicroRNAs (miRNAs) are small non-coding RNAs crucial for regulating cell functions like proliferation and differentiation.
  • miRNAs offer therapeutic potential in cancer by targeting multiple oncogenic genes simultaneously.
  • Challenges in miRNA therapy include achieving specific, effective, and safe delivery into cancer cells.

Purpose of the Study:

  • To develop a targeted delivery strategy for therapeutic microRNAs in cancer therapy.
  • To systemically deliver miR-210 specifically to breast cancer cells.
  • To evaluate the efficacy of this delivery system in inhibiting breast cancer growth.

Main Methods:

  • A three-layered polyplex nanoparticle system was engineered for miRNA delivery.
  • Folic acid was incorporated as a targeting moiety to direct nanoparticles to cancer cells.
  • The system was used to deliver miR-210 into breast cancer cells in vivo.

Main Results:

  • The polyplex system successfully achieved systemic delivery of miR-210 to breast cancer cells.
  • Targeted delivery of miR-210 resulted in significant inhibition of breast cancer growth.
  • The strategy demonstrated specificity and effectiveness in preclinical models.

Conclusions:

  • Targeted delivery of miRNAs using engineered polyplexes is a promising strategy for cancer therapy.
  • This approach overcomes key challenges in miRNA delivery, enhancing therapeutic potential.
  • The folic acid-targeted polyplex system offers a safe and effective method for inhibiting breast cancer progression.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.4K
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
62
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K